Pharmacological probes for A1 and A2 adenosine receptors in vivo in feline pulmonary vascular bed

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 2 39-2, 1996, Pages

  Neely, Constance Fisher ^a,b   Matot, Idit ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

pulmonary vascular pharmacology; pulmonary vascular resistance; pulmonary vasoreactivity

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 ANILINOADENOSINE; 2 CHLOROADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR STIMULATING AGENT; BW A1433U; GLYCERYL TRINITRATE; PHENYLISOPROPYLADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; PROSTAGLANDIN ENDOPEROXIDE; THROMBOXANE A2; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELECTIVITY; HEART LEFT ATRIUM PRESSURE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION; ADRENERGIC SYSTEM; ANIMAL; BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; LUNG CIRCULATION; METABOLISM; PHYSIOLOGY; VASCULAR RESISTANCE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BLOOD VESSELS; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; PULMONARY CIRCULATION; RECEPTORS, PURINERGIC P1; THROMBOXANE A2; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASOMOTOR SYSTEM;

EID: 0029930526     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.2.h610     Document Type: Article

References (37)

1. 2 receptors. Eur. J. Pharmacol. 227: 317-324, 1992.
2. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29: 331-346, 1986.
3. Bruns, R. F., G. H. Lu, and T. A. Pugsley. Adenosine receptor subtypes: binding studies. In: Topics and Perspectives in Adenosine Research, edited by E. Gerlach and B. F. Becker. Berlin: Springer-Verlag, 1987, p. 59-73.
4. 3H]CV-1808) labels a novel adenosine receptor in rat brain. J. Pharmacol. Exp. Ther. 263: 552-561, 1992.
5. 2 adenosine receptors in the ventral aorta of the dogfish shark, Squalus acanthias. J. Comp. Physiol. B Biochem. Syst. Environ. Physiol. 162: 179-183, 1992.
6. 2-selective adenosine antagonists: in vivo characterization of cardiovascular effects. J. Pharmacol. Exp. Ther. 242: 882-887, 1987.
7. Fredholm, B. B., K. A. Jacobson, B. Jonzon, K. L. Kirk, Y. O. Li, and J. W. Daly. Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo. J. Cardiovasc. Pharmacol. 9: 396-400, 1987.
8. 2b, subtype (Abstract). Br. J. Pharmacol. 102: 198P, 1991.
9. 2) in the cat. Circ. Res. 45: 404-409, 1979.
10. Jacobson, K. A., P. J. M. van Galen, and M. Williams. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 35: 407-422, 1992.
11. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251: 888-893, 1989.
12. Kadowitz, P. J., and A. L. Hyman. Effect of sympathetic nerve stimulation on pulmonary vascular resistance in the dog. Circ. Res. 32: 221-227, 1973.
13. Kellett, R., C. J. Bowmer, M. G. Collis, and M. S. Yates. Amelioration of glycerol-induced acute renal failure in the rat with 8-cyclopentyl-1,3-dipropylxanthine. Br. J. Pharmacol. 98: 1066-1074, 1989.
14. King, A. D., M. Milavec-Krizman, and E. Muller-Schweinitzer. Characterization of the adenosine receptor in porcine coronary arteries. Br. J. Pharmacol. 100: 483-486, 1990
15. Knight, R. J., M. G. Collis, M. S. Yates, and C. J. Bowmer. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine. Br. J. Pharmacol. 104: 1062-1068. 1991.
16. 2 receptor interactions in vivo. J. Pharmacol. Exp Ther. 263: 657-662, 1992.
17. 6-alkyl subregion. J. Med. Chem. 28: 1636-1643.1985.
18. 1 adenosine receptors. FASEB J. 5: 2668-2676, 1991.
19. 3 adenosine receptor with widespread distribution. Mol. Pharmacol. 44: 524-532, 1993.
20. Londos, C., D. M. F. Cooper, W. Schlegel, and M. Rodbell. Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis Proc. Natl. Acad. Sci. USA 75: 5362-5366. 1978.
21. Londos, C., D. M. F. Cooper, and J. Wolff. Subclasses of external adenosine receptors. Prof. Natl. Acad. Sci. USA 77: 2551-2554, 1980.
22. 2 receptor agonists CGS 21680 and CGS 22492 in human vasculature. Eur. J. Pharmacol. 221: 243-247, 1992.
23. 2-purinoceptors. Br. J. Pharmacol. 103: 1103-1107, 1991.
24. McCormack, D. G., B. Clarke, and P. J. Barnes. Characterization of adenosine receptors in human pulmonary arteries. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H41-H46, 1989.
25. Neely, C. F. Purinergic responses in the feline pulmonary vascular bed. Drug Dev. Res. 28: 328-335, 1993.
26. Neely, C. F., D. M. Haile, B. E. Cahill, and P. J. Kadowitz. Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms. J. Pharmacol. Exp. Ther. 258: 753-761, 1991.
27. Neely, C. F., P. J. Kadowitz, H. Lippton, M. Neiman, and A. L. Hyman. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5′ triphosphate in the feline pulmonary vascular bed. J. Pharmacol. Exp. Ther. 250: 170-176, 1989
28. 2 adenosine receptors by two antipeptide antibody preparations. Mol. Pharmacol. 42: 391-397, 1992.
29. 2 adenosine receptor. Anesth. Analg. 79: 46-51, 1994.
30. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol. Chem. 268: 16887-16890, 1993.
31. 2-adenosine receptor subtype. Mol. Endocrinol. 6: 384-393, 1992.
32. 2 receptors in guinea-pig aorta. Eur. J. Pharmacol. 190: 329-335, 1990.
33. 2 receptors. In: Adenosine and Adenosine Receptors, edited by M. Williams. Clifton, NJ: Humana, 1990, p. 57-103.
34. 2 receptors. Can. J. Physiol. Pharmacol. 65: 365-376, 1987.
35. Van Calker, D., M. Muller, and B. Hambrecht. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33. 999-1005, 1979
36. 2 receptors: structure-function relationships. Med. Res. Rev. 12: 423-471, 1992.
37. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89: 7432-7436, 1992.